1-Cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

Cyclobutane-1,3-diol, 97%, 500mg

6-BROMO-5-CHLORO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 5g

N-Phenylmethacrylamide, 99%, 100g

6-Bromo-imidazo[1,2-a]pyridine-2-carboxylic acid hydrobromide, 1g

1-BENZYL-4-OXOPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 5g

Dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, 97.0%, 1g

Filtres pour seringues ROTILABO® MCE, 0,45 µm, 100 Pièce(s)

1-(4-Chloro-2-(5-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethan-1-one, 98+%, 1g

1-(4-BROMO-2-METHYLPHENYL)ETHANONE, 95.0%, 5g

2-(4-((3-Chlorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

Standard Mixture of Fatty Acid Methyl Esters (consists of Methyl Formate, Acetate, Propionate, Butyrate and Valerate) [Standard Material for GC]5mL

4-Bromo-2-ethoxypyridine, 95.0%, 250mg